Metraipolis › archive › dc_f77ee9a7bc4a

Transcending risk factors: the implications of redefining diabetes as an immunometabolic disease for infectious disease studies — Europe PMC PMID:41909674

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41909674
DOI
10.3389/fimmu.2026.1794628
License (as archived)
solo-consultazione
Archived
2026-11-04T10:00:44.073Z
SHA-256 of the archived text
c32c10ac8339cf21e6e66ae9e8812c55641076f58911461424c383a1258f581b
Stable URL of this page
https://metraipolis.com/documento/dc_f77ee9a7bc4a

How to cite

Transcending risk factors: the implications of redefining diabetes as an immunometabolic disease for infectious disease studies — Europe PMC PMID:41909674 — Europe PMC (en), https://europepmc.org/article/MED/41909674 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f77ee9a7bc4a (Metraipolis archive dc_f77ee9a7bc4a, sha256 c32c10ac8339cf21e6e66ae9e8812c55641076f58911461424c383a1258f581b)
BibTeX
@misc{dcf77ee9a7bc4a,
  title = {Transcending risk factors: the implications of redefining diabetes as an immunometabolic disease for infectious disease studies — Europe PMC PMID:41909674},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41909674},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f77ee9a7bc4a; sha256 c32c10ac8339cf21e6e66ae9e8812c55641076f58911461424c383a1258f581b},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41909674. Agents can read the archived copy with the MCP tool read_document.